CN105816761A - Traditional Chinese medicine used in cooperation with cancer radiation - Google Patents
Traditional Chinese medicine used in cooperation with cancer radiation Download PDFInfo
- Publication number
- CN105816761A CN105816761A CN201610290022.5A CN201610290022A CN105816761A CN 105816761 A CN105816761 A CN 105816761A CN 201610290022 A CN201610290022 A CN 201610290022A CN 105816761 A CN105816761 A CN 105816761A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- herba
- radix
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to traditional Chinese medicine used in cooperation with cancer radiation. The traditional Chinese medicine is composed of, by mass, 16-20 parts of helianthus tuberosus L., 18-22 parts of bombyx batryticatus, 14-18 parts of herba taraxac, 12-16 parts of semen cassia, 18-22 parts of Chinese sage herbs, 14-18 parts of myotonin, 12-16 parts of rhizoma polygonati odorati, 18-22 parts of pseudobulb of appendiculate cremastra, 14-18 parts of pericarpium citri reticulatae, 12-16 parts of rhizoma paridis, 18-22 parts of common burreed rhizome, 14-18 parts of receptaculum nelumbinis, 14-18 parts of Chinese astilbe herbs, 12-16 parts of rhizoma corydalis, 18-22 parts of fructus toosendan, 14-18 parts of herba agrimoniae, 12-16 parts of radix et rhizoma rhei, 18-22 parts of radix paeoniae rubra, marsdenia tenacissima, 12-16 parts of herba pogostemonis, 18-22 parts of Indian mockstrawberrg herbs, 14-18 parts of embelia parviflora wall and 12-16 parts of rhizome of manyleaf Paris. All traditional Chinese medical materials are compatible and have the effects of nourishing the kidney and benefiting essence, tonifying the liver and the kidney, nourishing qi and blood, tonifying the spleen and the stomach, adjusting the physiological function of the human body and improving immunity.
Description
Technical field
The present invention relates to a kind of Chinese medicine coordinating cancer radiation, belong to cancer radiation technical field.
Background technology
Radiotherapy is a kind of method utilizing ionizing radiation treatment tumor.The radioactive source used mainly has three classes: one is the α of radiation isotope injection, β, gamma-rays;Two is the X-ray of the different-energy of x-ray therapy apparatus and the generation of all kinds of accelerator;Three is the electron beam of all kinds of accelerator generation, neutron beam, negative πmeson bundle plasma ray.These rays have different penetration capacitys, can destroy human tissue cell's internal component, directly or indirectly act on DNA molecular, suppress or kill tumor cell.The tumor patient that there are about 60%~70% accepts radiotherapy.At present, radiotherapy and operation, chemotherapy are three big primary treatments of cancer altogether.Though radiotherapy can destroy or eliminate cancerous cell, and also damages normal cell simultaneously, its toxic and side effects can be divided into acute and chronic two kinds.Acute side effects is more easy to occur at the fast tissue of renewal speed, such as skin, intestinal mucosa, bone marrow and reproductive system etc., can treatment soon within several days the most several hours, begin to occur, such as degradation digestive tract reaction under Nausea and vomiting, appetite, the hematopoietic repair such as leukopenia, platelet reduction, myxedema, radiation pneumonia, pigmentation etc..Chronic side effect may need some months the most progressively to display for the most several years, but it is the most permanent, once occur i.e. to be difficult to correct, cause blood supply not enough mainly due to the damage of connective tissue of blood vessels interstitial, occur that epithelial proliferation and fibrosis etc. are caused, and the dosage of single radiotherapy is the biggest, the incidence rate of late morbidity is the highest, such as Brain Radiation Injury, Radiation induced myelopathy, radiation fibrosis of lung etc..
Summary of the invention
It is an object of the invention to provide a kind of Chinese medicine coordinating cancer radiation, in order to preferably coordinate cancer radiation.
To achieve these goals, technical scheme is as follows.
nullA kind of Chinese medicine coordinating cancer radiation,It is made up of the component of following mass fraction: Jerusalem artichoke 16~20 parts、Bombyx Batryticatus 18~22 parts、Herba Taraxaci 14~18 parts、Semen Cassiae 12~16 parts、Herba Salviae Chinensis 18~22 parts、Seed of Job's tears 14~18 parts、Rhizoma Polygonati Odorati 12~16 parts、Pseudobulbus cremastrae seu pleiones 18~22 parts、Pericarpium Citri Reticulatae 14~18 parts、Rhizoma Paridis 12~16 parts、Rhizoma Sparganii 18~22 parts、Receptaculum Nelumbinis 14~18 parts、Herba astilbes chinensis 14~18 parts、Rhizoma Corydalis 12~16 parts、Fructus Toosendan 18~22 parts、Herba Agrimoniae 14~18 parts、Radix Et Rhizoma Rhei 12~16 parts、Radix Paeoniae Rubra 18~22 parts、Caulis Marsdeniae Tenacissimae 14~18 parts、Herba Pogostemonis 12~16 parts、Herba Duchesneae Indicae 18~22 parts、Radix seu Caulis Embeliae Parviflorae 14~18 parts、Rhizoma Paridis 12~16 parts、Rhizoma Smilacis Scobinicaulis 18~22 parts、Semen Lini 14~18 parts、Radix Paeoniae Rubra 14~18 parts、Fructus Mori 14~18 parts、Rhizoma Begoniae Willsonii 14~18 parts.
Further, the Chinese medicine of above-mentioned cooperation cancer radiation, it is made up of the component of following mass fraction: Jerusalem artichoke 16 parts, Bombyx Batryticatus 18 parts, Herba Taraxaci 14 parts, Semen Cassiae 12 parts, Herba Salviae Chinensis 18 parts, seed of Job's tears 14 parts, Rhizoma Polygonati Odorati 12 parts, Pseudobulbus cremastrae seu pleiones 18 parts, Pericarpium Citri Reticulatae 14 parts, Rhizoma Paridis 12 parts, Rhizoma Sparganii 18 parts, Receptaculum Nelumbinis 14 parts, Herba astilbes chinensis 14 parts, Rhizoma Corydalis 12 parts, Fructus Toosendan 18 parts, Herba Agrimoniae 14 parts, Radix Et Rhizoma Rhei 12 parts, Radix Paeoniae Rubra 18 parts, Caulis Marsdeniae Tenacissimae 14 parts, Herba Pogostemonis 12 parts, Herba Duchesneae Indicae 18 parts, Radix seu Caulis Embeliae Parviflorae 14 parts, Rhizoma Paridis 12 parts, Rhizoma Smilacis Scobinicaulis 18 parts, Semen Lini 14 parts, Radix Paeoniae Rubra 14 parts, Fructus Mori 14 parts, Rhizoma Begoniae Willsonii 14 parts.
Further, the Chinese medicine of above-mentioned cooperation cancer radiation, it is made up of the component of following mass fraction: Jerusalem artichoke 18 parts, Bombyx Batryticatus 20 parts, Herba Taraxaci 16 parts, Semen Cassiae 14 parts, Herba Salviae Chinensis 20 parts, seed of Job's tears 16 parts, Rhizoma Polygonati Odorati 14 parts, Pseudobulbus cremastrae seu pleiones 20 parts, Pericarpium Citri Reticulatae 16 parts, Rhizoma Paridis 14 parts, Rhizoma Sparganii 20 parts, Receptaculum Nelumbinis 16 parts, Herba astilbes chinensis 16 parts, Rhizoma Corydalis 14 parts, Fructus Toosendan 20 parts, Herba Agrimoniae 16 parts, Radix Et Rhizoma Rhei 14 parts, Radix Paeoniae Rubra 20 parts, Caulis Marsdeniae Tenacissimae 16 parts, Herba Pogostemonis 14 parts, Herba Duchesneae Indicae 20 parts, Radix seu Caulis Embeliae Parviflorae 16 parts, Rhizoma Paridis 14 parts, Rhizoma Smilacis Scobinicaulis 20 parts, Semen Lini 16 parts, Radix Paeoniae Rubra 16 parts, Fructus Mori 16 parts, Rhizoma Begoniae Willsonii 16 parts.
Further, the Chinese medicine of above-mentioned cooperation cancer radiation, it is made up of the component of following mass fraction: Jerusalem artichoke 20 parts, Bombyx Batryticatus 22 parts, Herba Taraxaci 18 parts, Semen Cassiae 16 parts, Herba Salviae Chinensis 22 parts, seed of Job's tears 18 parts, Rhizoma Polygonati Odorati 16 parts, Pseudobulbus cremastrae seu pleiones 22 parts, Pericarpium Citri Reticulatae 18 parts, Rhizoma Paridis 16 parts, Rhizoma Sparganii 22 parts, Receptaculum Nelumbinis 18 parts, Herba astilbes chinensis 18 parts, Rhizoma Corydalis 16 parts, Fructus Toosendan 22 parts, Herba Agrimoniae 18 parts, Radix Et Rhizoma Rhei 16 parts, Radix Paeoniae Rubra 22 parts, Caulis Marsdeniae Tenacissimae 18 parts, Herba Pogostemonis 16 parts, Herba Duchesneae Indicae 22 parts, Radix seu Caulis Embeliae Parviflorae 18 parts, Rhizoma Paridis 16 parts, Rhizoma Smilacis Scobinicaulis 22 parts, Semen Lini 18 parts, Radix Paeoniae Rubra 18 parts, Fructus Mori 18 parts, Rhizoma Begoniae Willsonii 18 parts.
Chinese medicine all medicines compatibility of the present invention, there is training kidney benefit essence, invigorating the liver and kidney, qi and blood invigorating, invigorating the spleen and regulating the stomach effect, regulate body physiological function, improve immunity, the symptoms such as too low, weak unable, the alopecia of leukocyte that effectively alleviation cancer radiation causes, improve the life quality of patient.Clinical with often receive good effect.In 4 years, by showing the use of 38 patients, effective percentage reaches 88.57%.
Below in conjunction with clinical laboratory data beneficial effects of the present invention is described:
1, physical data: inventor have collected 70 example cancer patient undergoing radiotherapies, wherein, 30 years old age~60 years old, the state of an illness 1 month~3 months altogether between in January ,-2016 in January, 2012.It is randomly divided into: treatment group 35 example, matched group 35 example.The data such as two groups of ages there was no significant difference, and has comparability.
2, test method: (1) matched group takes certain commercially available ass glue oral liquid, takes to specifications.14 days courses for the treatment of.(2) treatment group is administered orally the powder that the present invention prepares according to specific embodiment 2, early, middle and late each the most once.14 days courses for the treatment of.(3) criterion of therapeutical effect and therapeutic outcome: criterion of therapeutical effect: cure: all malaise symptoms all disappear, energy and muscle power substantially increase.Taking a turn for the better: all malaise symptoms alleviate or partial disappearance, energy and muscle power strengthen.Invalid: malaise symptoms is unchanged or increases the weight of.Effective percentage is calculated to cure and to take a turn for the better.Treatment statistical result is shown in Table 1.
1 liang of table group comparitive study
Visible, the Chinese medicine of the present invention is for being not suitable with symptom curative effect apparently higher than matched group after treatment cancer radiation, and effective percentage is high, is effectively improved the life quality of patient.
Toxicity test:
Test drug is the powder in the embodiment of the present invention 2.Experimental animal is ICR kind white mice, body weight 18~22 grams, male and female half and half, totally 40.Test method is, after fasting 12 hours, by 20 g kg to mice lavage 4 months, long term toxicity test result shows, white mice body weight, Liver and kidney function, hemogram etc. and matched group no significant difference, shows that the safety of this medicine is big, belongs to nontoxic rank.
Detailed description of the invention
Below in conjunction with embodiment, the detailed description of the invention of the present invention is described, in order to be better understood from the present invention.
Embodiment 1
The Chinese medicine coordinating cancer radiation in the present embodiment, weighs Jerusalem artichoke 16 grams, Bombyx Batryticatus 18 grams, Herba Taraxaci 14 grams, Semen Cassiae 12 grams, Herba Salviae Chinensis 18 grams, seed of Job's tears 14 grams, Rhizoma Polygonati Odorati 12 grams, Pseudobulbus cremastrae seu pleiones 18 grams, Pericarpium Citri Reticulatae 14 grams, Rhizoma Paridis 12 grams, Rhizoma Sparganii 18 grams, Receptaculum Nelumbinis 14 grams, Herba astilbes chinensis 14 grams, Rhizoma Corydalis 12 grams, Fructus Toosendan 18 grams, Herba Agrimoniae 14 grams, Radix Et Rhizoma Rhei 12 grams, Radix Paeoniae Rubra 18 grams, Caulis Marsdeniae Tenacissimae 14 grams, Herba Pogostemonis 12 grams, Herba Duchesneae Indicae 18 grams, Radix seu Caulis Embeliae Parviflorae 14 grams, Rhizoma Paridis 12 grams, Rhizoma Smilacis Scobinicaulis 18 grams, Semen Lini 14 grams, Radix Paeoniae Rubra 14 grams, Fructus Mori 14 grams, Rhizoma Begoniae Willsonii 14 grams.Add 6 times amount water, decoct 2 hours, filter;Filtering residue adds 8 times amount water, decocts 1 hour, filters;Merging filtrate, concentrates, and is dried, mix homogeneously, loads capsule shells, must meet and treat with the capsule of 1 day consumption.For cancer patient undergoing radiotherapy, oral, every bu is taken for early, middle and late three times.
Embodiment 2
The Chinese medicine coordinating cancer radiation in the present embodiment, weighs Jerusalem artichoke 18 grams, Bombyx Batryticatus 20 grams, Herba Taraxaci 16 grams, Semen Cassiae 14 grams, Herba Salviae Chinensis 20 grams, seed of Job's tears 16 grams, Rhizoma Polygonati Odorati 14 grams, Pseudobulbus cremastrae seu pleiones 20 grams, Pericarpium Citri Reticulatae 16 grams, Rhizoma Paridis 14 grams, Rhizoma Sparganii 20 grams, Receptaculum Nelumbinis 16 grams, Herba astilbes chinensis 16 grams, Rhizoma Corydalis 14 grams, Fructus Toosendan 20 grams, Herba Agrimoniae 16 grams, Radix Et Rhizoma Rhei 14 grams, Radix Paeoniae Rubra 20 grams, Caulis Marsdeniae Tenacissimae 16 grams, Herba Pogostemonis 14 grams, Herba Duchesneae Indicae 20 grams, Radix seu Caulis Embeliae Parviflorae 16 grams, Rhizoma Paridis 14 grams, Rhizoma Smilacis Scobinicaulis 20 grams, Semen Lini 16 grams, Radix Paeoniae Rubra 16 grams, Fructus Mori 16 grams, Rhizoma Begoniae Willsonii 16 grams.Add 10 times amount water, decoct 2 hours, filter;Filtering residue adds 8 times amount water, decocts 1.5 hours, filters;Merging filtrate, concentrates, and is dried, and closes uniformly, and packaging must meet and treat with the powder of 1 day consumption.For cancer patient undergoing radiotherapy, oral, every bu is taken for early, middle and late three times.
Embodiment 3
The Chinese medicine coordinating cancer radiation in the present embodiment, weighs Jerusalem artichoke 20 grams, Bombyx Batryticatus 22 grams, Herba Taraxaci 18 grams, Semen Cassiae 16 grams, Herba Salviae Chinensis 22 grams, seed of Job's tears 18 grams, Rhizoma Polygonati Odorati 16 grams, Pseudobulbus cremastrae seu pleiones 22 grams, Pericarpium Citri Reticulatae 18 grams, Rhizoma Paridis 16 grams, Rhizoma Sparganii 22 grams, Receptaculum Nelumbinis 18 grams, Herba astilbes chinensis 18 grams, Rhizoma Corydalis 16 grams, Fructus Toosendan 22 grams, Herba Agrimoniae 18 grams, Radix Et Rhizoma Rhei 16 grams, Radix Paeoniae Rubra 22 grams, Caulis Marsdeniae Tenacissimae 18 grams, Herba Pogostemonis 16 grams, Herba Duchesneae Indicae 22 grams, Radix seu Caulis Embeliae Parviflorae 18 grams, Rhizoma Paridis 16 grams, Rhizoma Smilacis Scobinicaulis 22 grams, Semen Lini 18 grams, Radix Paeoniae Rubra 18 grams, Fructus Mori 18 grams, Rhizoma Begoniae Willsonii 18 grams.Add 8 times amount water, decoct 1.5 hours, filter;Filtering residue adds 6 times amount water, decocts 1 hour, filters;Merging filtrate, concentrates, and is dried, mix homogeneously, pelletizes according to this area common process, packaging, must meet and treat with the granule of 1 day consumption.For cancer patient undergoing radiotherapy, oral, every bu is taken for early, middle and late three times.
The above is the preferred embodiment of the present invention; it should be pointed out that, for those skilled in the art, under the premise without departing from the principles of the invention; can also make some improvements and modifications, these improvements and modifications are also considered as protection scope of the present invention.
Claims (4)
- null1. the Chinese medicine coordinating cancer radiation,It is characterized in that: be made up of the component of following mass fraction: Jerusalem artichoke 16~20 parts、Bombyx Batryticatus 18~22 parts、Herba Taraxaci 14~18 parts、Semen Cassiae 12~16 parts、Herba Salviae Chinensis 18~22 parts、Seed of Job's tears 14~18 parts、Rhizoma Polygonati Odorati 12~16 parts、Pseudobulbus cremastrae seu pleiones 18~22 parts、Pericarpium Citri Reticulatae 14~18 parts、Rhizoma Paridis 12~16 parts、Rhizoma Sparganii 18~22 parts、Receptaculum Nelumbinis 14~18 parts、Herba astilbes chinensis 14~18 parts、Rhizoma Corydalis 12~16 parts、Fructus Toosendan 18~22 parts、Herba Agrimoniae 14~18 parts、Radix Et Rhizoma Rhei 12~16 parts、Radix Paeoniae Rubra 18~22 parts、Caulis Marsdeniae Tenacissimae 14~18 parts、Herba Pogostemonis 12~16 parts、Herba Duchesneae Indicae 18~22 parts、Radix seu Caulis Embeliae Parviflorae 14~18 parts、Rhizoma Paridis 12~16 parts、Rhizoma Smilacis Scobinicaulis 18~22 parts、Semen Lini 14~18 parts、Radix Paeoniae Rubra 14~18 parts、Fructus Mori 14~18 parts、Rhizoma Begoniae Willsonii 14~18 parts.
- The Chinese medicine of cooperation cancer radiation the most according to claim 1, it is characterized in that: described Chinese medicine is made up of the component of following mass fraction: Jerusalem artichoke 16 parts, Bombyx Batryticatus 18 parts, Herba Taraxaci 14 parts, Semen Cassiae 12 parts, Herba Salviae Chinensis 18 parts, seed of Job's tears 14 parts, Rhizoma Polygonati Odorati 12 parts, Pseudobulbus cremastrae seu pleiones 18 parts, Pericarpium Citri Reticulatae 14 parts, Rhizoma Paridis 12 parts, Rhizoma Sparganii 18 parts, Receptaculum Nelumbinis 14 parts, Herba astilbes chinensis 14 parts, Rhizoma Corydalis 12 parts, Fructus Toosendan 18 parts, Herba Agrimoniae 14 parts, Radix Et Rhizoma Rhei 12 parts, Radix Paeoniae Rubra 18 parts, Caulis Marsdeniae Tenacissimae 14 parts, Herba Pogostemonis 12 parts, Herba Duchesneae Indicae 18 parts, Radix seu Caulis Embeliae Parviflorae 14 parts, Rhizoma Paridis 12 parts, Rhizoma Smilacis Scobinicaulis 18 parts, Semen Lini 14 parts, Radix Paeoniae Rubra 14 parts, Fructus Mori 14 parts, Rhizoma Begoniae Willsonii 14 parts.
- The Chinese medicine of cooperation cancer radiation the most according to claim 1, it is characterized in that: described Chinese medicine is made up of the component of following mass fraction: Jerusalem artichoke 18 parts, Bombyx Batryticatus 20 parts, Herba Taraxaci 16 parts, Semen Cassiae 14 parts, Herba Salviae Chinensis 20 parts, seed of Job's tears 16 parts, Rhizoma Polygonati Odorati 14 parts, Pseudobulbus cremastrae seu pleiones 20 parts, Pericarpium Citri Reticulatae 16 parts, Rhizoma Paridis 14 parts, Rhizoma Sparganii 20 parts, Receptaculum Nelumbinis 16 parts, Herba astilbes chinensis 16 parts, Rhizoma Corydalis 14 parts, Fructus Toosendan 20 parts, Herba Agrimoniae 16 parts, Radix Et Rhizoma Rhei 14 parts, Radix Paeoniae Rubra 20 parts, Caulis Marsdeniae Tenacissimae 16 parts, Herba Pogostemonis 14 parts, Herba Duchesneae Indicae 20 parts, Radix seu Caulis Embeliae Parviflorae 16 parts, Rhizoma Paridis 14 parts, Rhizoma Smilacis Scobinicaulis 20 parts, Semen Lini 16 parts, Radix Paeoniae Rubra 16 parts, Fructus Mori 16 parts, Rhizoma Begoniae Willsonii 16 parts.
- The Chinese medicine of cooperation cancer radiation the most according to claim 1, it is characterized in that: described Chinese medicine is made up of the component of following mass fraction: Jerusalem artichoke 20 parts, Bombyx Batryticatus 22 parts, Herba Taraxaci 18 parts, Semen Cassiae 16 parts, Herba Salviae Chinensis 22 parts, seed of Job's tears 18 parts, Rhizoma Polygonati Odorati 16 parts, Pseudobulbus cremastrae seu pleiones 22 parts, Pericarpium Citri Reticulatae 18 parts, Rhizoma Paridis 16 parts, Rhizoma Sparganii 22 parts, Receptaculum Nelumbinis 18 parts, Herba astilbes chinensis 18 parts, Rhizoma Corydalis 16 parts, Fructus Toosendan 22 parts, Herba Agrimoniae 18 parts, Radix Et Rhizoma Rhei 16 parts, Radix Paeoniae Rubra 22 parts, Caulis Marsdeniae Tenacissimae 18 parts, Herba Pogostemonis 16 parts, Herba Duchesneae Indicae 22 parts, Radix seu Caulis Embeliae Parviflorae 18 parts, Rhizoma Paridis 16 parts, Rhizoma Smilacis Scobinicaulis 22 parts, Semen Lini 18 parts, Radix Paeoniae Rubra 18 parts, Fructus Mori 18 parts, Rhizoma Begoniae Willsonii 18 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610290022.5A CN105816761A (en) | 2016-04-29 | 2016-04-29 | Traditional Chinese medicine used in cooperation with cancer radiation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610290022.5A CN105816761A (en) | 2016-04-29 | 2016-04-29 | Traditional Chinese medicine used in cooperation with cancer radiation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105816761A true CN105816761A (en) | 2016-08-03 |
Family
ID=56527992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610290022.5A Withdrawn CN105816761A (en) | 2016-04-29 | 2016-04-29 | Traditional Chinese medicine used in cooperation with cancer radiation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105816761A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101502636A (en) * | 2009-03-05 | 2009-08-12 | 张晋玮 | Pure medicinal formulation for treating cancer and preparation method thereof |
CN102861292A (en) * | 2012-09-18 | 2013-01-09 | 李保明 | Medicament for treating esophageal cancer and preparation method thereof |
CN105106545A (en) * | 2015-09-24 | 2015-12-02 | 苏毅 | Traditional Chinese medicine composition cooperating for radiotherapy of cancers |
-
2016
- 2016-04-29 CN CN201610290022.5A patent/CN105816761A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101502636A (en) * | 2009-03-05 | 2009-08-12 | 张晋玮 | Pure medicinal formulation for treating cancer and preparation method thereof |
CN102861292A (en) * | 2012-09-18 | 2013-01-09 | 李保明 | Medicament for treating esophageal cancer and preparation method thereof |
CN105106545A (en) * | 2015-09-24 | 2015-12-02 | 苏毅 | Traditional Chinese medicine composition cooperating for radiotherapy of cancers |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
CN102038758B (en) | Rheumatism preparation used for treating rheumatism | |
CN103127422B (en) | Medicament for treating ulcerative colitis | |
CN101091769B (en) | Medicine for treating and preventing esophagus cancer and gastric cancer, and preparation method | |
CN1183919C (en) | Cancer treating medical composition | |
CN103405719A (en) | Medicament for treatment of depression | |
CN105079400A (en) | Pharmaceutical preparation for treating osteoporosis | |
CN102973758A (en) | Traditional Chinese medicine composition for treating depression | |
CN107854565B (en) | Anti-radiation traditional Chinese medicine composition | |
CN102240302B (en) | Chinese medicine composition of super gene active peptide | |
CN105816761A (en) | Traditional Chinese medicine used in cooperation with cancer radiation | |
CN103479872A (en) | Medicament for treating infantile pneumonia | |
CN103272159A (en) | Chinese herbal preparation used for treating consumptive disease and preparation method thereof | |
CN103948878B (en) | A kind of Chinese medicine composition for the treatment of osteopathia | |
CN105616962A (en) | Traditional Chinese medicine cooperative with cancer radiotherapy | |
CN102266434B (en) | Chinese medicinal composition for resisting tumor metastasis and preparation method thereof | |
CN104383097A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
CN104857276B (en) | A kind of Chinese medicine for treating syndrome of deficiency of both qi and yin after malignant tumour Radiotherapy chemotherapy | |
CN1136939A (en) | Chinese drugs for curing hepatitis B | |
CN1207034C (en) | Huanyang blood-changing pill and its preparation method | |
CN101721610B (en) | Medicine for treating tumors | |
CN105362999A (en) | Traditional Chinese medicine preparation for preventing and treating infantile repeated cold and preparation method thereof | |
CN105213927A (en) | A kind of medicine for the treatment of acute enteritis and preparation method thereof | |
CN105688019A (en) | Prescription of traditional Chinese medicine for treating lymphoma | |
CN104758749A (en) | Traditional Chinese medicine composition for treating liver cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160803 |
|
WW01 | Invention patent application withdrawn after publication |